logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

Aassessment of respiratory system functional state in patients with chronic rheumatic heart disease

[Original research]
Vadim Sergeevich Petrov;

The state of external respiration function was studied in 113 patients with rheumatic heart disease over a period of 5 years. Against the background of a significant decrease in the area of the mitral orifice by 0.22 cm2, reduction of the test distance of 6-minutes walking by 33.54 meters, obstructive and restrictive indices decreased. Lung vital capacity (VC) decreased by 16.46 %, forced VC (FVC) decreased by 5.31 %, and forced expiratory volume in 1 second (FEV1) by 3.09 %. There was significant decrease in VC, FVC, and FEV1 in the groups studied with III–IV functional class (FC) CHF compared with the I–II FC CHF. Spirometry was lower in the study group with atrial fibrillation when compared with patients with sinus rhythm: VC by 15.62 %, FVC by 12.13 %, FEV1 by 15.63 %.

Download

References:
1.Yakushin S. S., Filippov E. V. The main directions of the primary prevention of cardiovascular disease. Nauka molodykh. – Eruditio Juvenium. 2014;4:55-68. (In Russ.).
2. Mareev V. U., Ageev F. T., Arutyunov G. P., Koroteev A. V., Revishvili A. S. Nacionalnye rekomendacii vnok I ossn po diagnostike I lecheniyu hsn (tretij
peresmotr). Zhurnal serdechnaya nedostatochnost. –Journal of Heart Failure. 2010;11(1):3-62. (In Russ.).
3. Dalsgaard M., Plesner L. L., Schou M., Kjøller E., Vestbo J., Iversen K. Prevalence of airflow obstruction in patients with stable systolic heart failure. BMC Pulmonary Med. 2017;17:1-8. https://doi.org/10.1186/s12890-016-0351-9
4. El-Sobkey S. B., Gomaa M. Assessment of pulmonary function tests in cardiac patients. J. Saudi Heart Assoc. 2011;23(2):81-86. https://doi.org/10.1016/j.jsha.2011.01.003
5. Kader W. A. A., Kasim S. E., Marbut M. M. The pattern of spirometric abnormalities in patient with ischemic heart failure in Tikreet. Tikrit Med. J. 2011;17(1):169-176.
6. Mahendra M., Kumar S., Desai N., Jayaraj B. S., Mahesh P. A. Evaluation for airway obstruction in adult patients with stable ischemic heart disease. Indian Heart J. 2018;70:266-271.
7. Zotova L. A., Petrov V. S., Vuleh V. M., Trunina T. P. Case restrictive cardiomyopathy in real clinical practice. Nauka molodykh. – Eruditio Juvenium. 2018;1:74-86 (In Russ). https://doi.org/10.23888/HMJ2018174-86
8. Guder G., Brenner S., Stork S., Hoes A., Rutten F. H. Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment. Eur. J. Heart Fail. 2014;16:1273-1282.
9. Canepa M., Zambito P. E., Brusasco V., Meinertz T., Rosenkranz S. What can we learn from pulmonary function testing in heart failure? Eur. J. Heart Fail. 2017;19:1222-1229. https://doi.org/10.1002/ejhf.946
10. Abraham W. T., Stevenson L. W., Bourge R. C., Lindenfeld J. A., Bauman J. G., Adamson P. B. CHAMPION Trial Study Group. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet. 2016;387:453-461. https://doi.org/10.1016/S0140-6736(15)00723-0
11. Melenovsky V., Andersen M. J., Andress K., Reddy Y. N., Borlaug B. A. Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications. Eur. J. Heart Fail. 2015;17:1161-1171.
12. Petrov V. S. Result of 5-year observation for patients with rheumatic heart disease. IP Pavlov Medical Biological Herald. 2015;(3):83-87. (In Russ.). https://doi.org/10.17816/pavlovj2015383-87
13. Shostak N. A., Klimenko A. A., Novikov I. V. Respiratory function in patients with rheumatic heart disease complicated with pulmonary hypertension. Rational Pharmacother. Card. 2011;7(1):26-30. (In Russ.).
14. Parvathy U. T., Rajan R., Faybushevich A. G. Pulmonary function derangements in isolated or predominant mitral stenosis – Preoperative evaluation with clinico-hemodynamic correlation. Interv. Med. Appl. Sci. 2014;6(2):75-84. https://doi.org/10.1556/IMAS.6.2014.2.4
15. Mundhra S. H., Mundhara K. S., Thakkar R. M., Ninama K., Parmar H. Pulmonary function test in mitral valve disease. Internat. Arch. Integr. Med. 2015;2(8):24-29.

Keywords: rheumatic heart disease, mitral stenosis, respiratory function


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy